Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Staggered versus concomitant dosing of artemether-lumefantrine and ciprofloxacin in malaria-typhoid coinfection
PACTR201909811770922Phase 1Completed
- Sponsor
- Tertiary Education Trust Fund
- Start
- Jun 2019
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of artemether + lumefantrine and ciprofloxacin in malaria and typhoid fever (2 arms), sponsored by Tertiary Education Trust Fund. Primary endpoint: Incidence of clinical and laboratory diagnosed malaria-typhoid coinfection. Started Jun 2019; status: completed.
02
Drugs
artemether + lumefantrineciprofloxacin
03
Conditions
malariatyphoid fever
Beyond the preview
Go deeper on PACTR201909811770922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201909811770922.